Thomas Schaser

Title: Thomas Schaser: Innovator in Targeted T Cell Transduction

Introduction

Thomas Schaser is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of targeted therapies for T cell subsets. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

One of Thomas Schaser's key patents is titled "CD62L specific lentiviral vector particle for targeted transduction of T cell subsets." This invention provides a composition that includes a pseudotyped retroviral vector particle. The vector particle comprises an envelope protein with antigen-binding activity, which is a recombinant protein that does not interact with at least one of its original receptors. This invention aims to enhance the specificity and efficacy of T cell targeting, which is crucial for developing effective immunotherapies.

Career Highlights

Thomas Schaser is currently employed at Miltenyi Biotec B.V. Co., Kg, where he continues to work on innovative solutions in the field of cell and gene therapy. His career is marked by a commitment to research and development, focusing on improving therapeutic strategies for various diseases.

Collaborations

Throughout his career, Thomas has collaborated with talented individuals such as Andrew Kaiser and Laura Kapitza. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Thomas Schaser's contributions to the field of biotechnology, particularly through his patent on targeted T cell transduction, highlight his role as an innovator. His work at Miltenyi Biotec and collaborations with colleagues further emphasize his commitment to advancing medical science.